DTx Pharma
San Diego
About DTx Pharma
DTx Pharma develops technology that will unleash RNA-based therapeutics as the modality of choice for personalized treatment across therapeutic areas. DTx Pharma believes its approach to delivering RNA medicines solves some of the issues that limited previous-generation platforms, including poor pharmacokinetics and insufficient cellular uptake.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $113.6M
- Funding stage: M&A
- Last round: Series B (Mar 2021)
- Website: dtxpharma.com
- Phone: (858) 366-3243
Industries & Categories
Biotechnology, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/dtx-pharma-22382 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.